ZIMMER BIOMET HOLDINGS, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $8.2 | $7.7 | $7.4 | $6.9 | $6.8 |
| Operating income | $1.1 | $1.3 | $1.3 | $0.7 | $0.9 |
| Net income | $0.7 | $0.9 | $1.0 | $0.2 | $0.4 |
| Balance Sheet | |||||
| Total debt | — | — | $5.8 | $5.7 | $7.1 |
| Cash Flow Statement | |||||
| Free cash flow | $1.5 | $1.3 | $1.3 | $1.2 | $1.4 |
| Dividends | $0.2 | $0.2 | $0.2 | $0.2 | $0.2 |
| Share repurchases | $0.5 | $0.9 | $0.7 | $0.1 | — |
Shares outstanding 190.7M · Free float 95.9%
Annual filing data through FY ended December 31, 2025; float as of October 10, 2026.